Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Aberg

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Journal of Clinical Laboratory Analysis|January 1, 1990
Prostaglandin production in chronic progressive multiple sclerosisJ A Aberg, L M Demers, P J Romano, et al.
HIV Clinical Trials|December 14, 2001
Presence of macrolide resistance in respiratory flora of HIV-Infected patients receiving either clarithromycin or azithromycin for Mycobacterium avium complex prophylaxisJ A Aberg, M K Wong, R Flamm, et al.
Journal of Clinical Microbiology|February 7, 2001
Invasive fungal sinusitis and meningitis due to Arthrographis kalrae in a patient with AIDSP V Chin-Hong, D A Sutton, M Roemer, et al.
HIV Clinical Trials|July 11, 2007
Safety and tolerability of sequential pegylated IFN-alpha2a and tenofovir for hepatitis B infection in HIV(+) individualsR M Johnson, M B Ristig, E T Overton, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 19, 2000
Sex differences in nevirapine rashS J Bersoff-Matcha, W C Miller, J A Aberg, et al.
Vaccine|March 15, 2011
Lower peripheral blood CD14+ monocyte frequency and higher CD34+ progenitor cell frequency are associated with HBV vaccine induced response in HIV infected individualsD D Anthony, T Umbleja, J A Aberg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 14, 2000
Preliminary guidelines for the evaluation and management of dyslipidemia in adults infected with human immunodeficiency virus and receiving antiretroviral therapy: Recommendations of the Adult AIDS Clinical Trial Group Cardiovascular Disease Focus GroupM P Dubé, D Sprecher, W K Henry, et al.
Vaccine|July 6, 2010
Immune response to hepatitis B vaccine in HIV-infected subjects using granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant: ACTG study 5220E T Overton, M Kang, M G Peters, et al.
Annals of Internal Medicine|October 3, 2000
Discontinuation of Mycobacterium avium complex prophylaxis in patients with antiretroviral therapy-induced increases in CD4+ cell count. A randomized, double-blind, placebo-controlled trial. AIDS Clinical Trials Group 362 Study TeamJ S Currier, P L Williams, S L Koletar, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Journal of Clinical Laboratory Analysis|January 1, 1990
Prostaglandin production in chronic progressive multiple sclerosisJ A Aberg, L M Demers, P J Romano, et al.
HIV Clinical Trials|December 14, 2001
Presence of macrolide resistance in respiratory flora of HIV-Infected patients receiving either clarithromycin or azithromycin for Mycobacterium avium complex prophylaxisJ A Aberg, M K Wong, R Flamm, et al.
Journal of Clinical Microbiology|February 7, 2001
Invasive fungal sinusitis and meningitis due to Arthrographis kalrae in a patient with AIDSP V Chin-Hong, D A Sutton, M Roemer, et al.
HIV Clinical Trials|July 11, 2007
Safety and tolerability of sequential pegylated IFN-alpha2a and tenofovir for hepatitis B infection in HIV(+) individualsR M Johnson, M B Ristig, E T Overton, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 19, 2000
Sex differences in nevirapine rashS J Bersoff-Matcha, W C Miller, J A Aberg, et al.
Vaccine|March 15, 2011
Lower peripheral blood CD14+ monocyte frequency and higher CD34+ progenitor cell frequency are associated with HBV vaccine induced response in HIV infected individualsD D Anthony, T Umbleja, J A Aberg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 14, 2000
Preliminary guidelines for the evaluation and management of dyslipidemia in adults infected with human immunodeficiency virus and receiving antiretroviral therapy: Recommendations of the Adult AIDS Clinical Trial Group Cardiovascular Disease Focus GroupM P Dubé, D Sprecher, W K Henry, et al.
Vaccine|July 6, 2010
Immune response to hepatitis B vaccine in HIV-infected subjects using granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant: ACTG study 5220E T Overton, M Kang, M G Peters, et al.
Annals of Internal Medicine|October 3, 2000
Discontinuation of Mycobacterium avium complex prophylaxis in patients with antiretroviral therapy-induced increases in CD4+ cell count. A randomized, double-blind, placebo-controlled trial. AIDS Clinical Trials Group 362 Study TeamJ S Currier, P L Williams, S L Koletar, et al.
Pageof 2